Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high30.300 03/08/16
52 week low14.550 23/05/17
52 week change -10.610 (-41.61%)
4 week volume1,957,487 27/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Result of AGM

Notification of the result of any voting at an AGM

Proposed amendment to AGM resolution

Miscellaneous medium priority announcements

Integumen IPO

Miscellaneous medium priority announcements

Enterprise Securities Market Notice

Annual Financial Report & Notice of AGM

Publication of a company's annual financial report

Issue of Equity

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

Venn Life Sciences swings to FY pretax loss

Venn Life Sciences has swung to a FY pretax loss after what it described as another strong year. "We have started 2017 wit...

Final Results

Announcement of full year/4th quarter financial results

Equity Research (VENN)

Venn Life Sciences Holdings plc
31/03/2017
Venn’s full year results last week highlighted some of the growing pains associated with high growth companies and bedding down significant acquisitions. The impressive 57% top line growth was...
Venn Life Sciences Holdings plc
22/03/2017
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients has...
Venn Life Sciences Holdings plc
08/11/2016
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has...

Latest discussion posts More

  • New update from Davy Stockbrokers

    Davy Stockbrokers issued a positive update on VENN last week. It's client-only, but there's a summary ...
    19-Apr-2017
    gretel
  • Hybridan's new note

    FYI here's Hybridan's summary and new forecasts from 2 weeks ago: "Continuing growth not recognised in current price. Underlying fundamentals remain strong. ?m 2015A ...
    18-Apr-2017
    gretel
  • Re: 50% of m/cap in cash/liquid assets

    In summary then, VENN now have against a #10m m/cap: - #3m of cash - #1.9m of Integumen shares at the current 4.5p bid price - a business turning over 18m euros and ...
    5-Apr-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY21%
D4T4 SOLUTIONS15%
REDSTONECON15%
ROCKHOPPER15%
SERICA15%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN